KKR Real Est Finance Tr Stock (NYSE: KREF)

Dernières nouvelles pour KKR Real Est Finance Tr (NYSE:KREF) Stock

KKR REAL ESTATE FINANCE TRUS

KKR Real Estate Finance

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

UBS analyst Douglas Harter maintains Starwood Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STWD#NYSE">STWD</a>) with a Neutral and raises the price target from $19.5 to $20.

News

Price Target

Analyst Ratings

STWD

UBS Maintains Neutral on Starwood Property Trust, Raises Price Target to $20

Trading Ideas

CYCC

Cyclacel Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 239.6%

Piper Sandler analyst Richard Repetto maintains Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) with a Overweight and raises the price target from $83 to $97.

NDAQ

Piper Sandler Maintains Overweight on Nasdaq, Raises Price Target to $97

WIIM

SXTP

60 Degrees Pharmaceuticals shares are trading lower after the company announced the pricing of a $10 million offering of 2.63 million shares and warrants at a combined price of $1.90.

Piper Sandler analyst Patrick Moley maintains MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) with a Neutral and raises the price target from $202 to $204.

MKTX

Piper Sandler Maintains Neutral on MarketAxess Holdings, Raises Price Target to $204

UBS analyst Douglas Harter maintains Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) with a Buy and raises the price target from $13 to $14.

RITM

UBS Maintains Buy on Rithm Capital, Raises Price Target to $14

Piper Sandler analyst Patrick Moley maintains Intercontinental Exchange (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) with a Overweight and raises the price target from $180 to $202.

Piper Sandler Maintains Overweight on Intercontinental Exchange, Raises Price Target to $202

Piper Sandler analyst Patrick Moley maintains Interactive Brokers Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) with a Overweight and raises the price target from $45.5 to $65.

IBKR

Piper Sandler Maintains Overweight on Interactive Brokers Group, Raises Price Target to $65

UBS analyst Eliana Merle maintains ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) with a Buy and raises the price target from $4 to $8.

PROK

UBS Maintains Buy on ProKidney, Raises Price Target to $8

Piper Sandler analyst Patrick Moley maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $283 to $296.

Piper Sandler Maintains Overweight on CME Group, Raises Price Target to $296

ANGO

ANGO stock has given up its prior gain. AngioDynamics shares were trading higher after the company reported better-than-expected Q4 financial results and issued FY26 revenue guidance above estimates.

Piper Sandler analyst Patrick Moley maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Neutral and raises the price target from $80 to $92.

SCHW

Piper Sandler Maintains Neutral on Charles Schwab, Raises Price Target to $92

Piper Sandler analyst Patrick Moley maintains Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) with a Overweight and raises the price target from $245 to $250.

CBOE

Piper Sandler Maintains Overweight on Cboe Global Markets, Raises Price Target to $250

Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) will release earnings results for the second quarter, after the <a href="https://www.benzinga.com/quote/aa/earnings">closing bell on Wednesday, July 16.</a>
Analysts expect the Pittsburgh, Pennsylvania-based company to report quarterly earnings at 51 cents per share, up from 16 cents per share in the year-ago period. Alcoa projects to report quarterly revenue at $2.96 billion, compared to $2.91 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On July 14, Alcoa and its joint venture partner announced that San Ciprián smelter operations will be delayed to mid-2026 following a national power outage.
Alcoa shares fell 4.2% to close at $29.79 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/AA/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Citigroup analyst Alexander Hacking reinstated a Buy rating with a price target of $42 on July 8, 2025. This analyst has an accuracy rate of 66%.</li>
<li>B. Riley Securities analyst Lucas Pipes maintained a Buy rating and cut the price target from $43 to $38 on June 24, 2025. This analyst has an accuracy rate of 68%.</li>
<li>UBS analyst Daniel Major downgraded the stock from Buy to Neutral with a price target of $31 on May 15, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Morgan Stanley analyst Carlos De Alba maintained an Overweight rating and cut the price target from $51 to $39 on April 9, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Jefferies analyst Chris LaFemina maintained a Buy rating and cut the price target from $50 to $45 on Jan. 6, 2025. This analyst has an accuracy rate of 62%.</li>
</ul>
Considering buying AA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/AA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="570" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15052529/image-164-1024x570.png" alt="" class="wp-image-985500" style="width:614px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15052529/image-164-1024x570.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15052529/image-164-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15052529/image-164-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15052529/image-164.png 1126w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46408189/jpmorgan-wells-fargo-and-3-stocks-to-watch-heading-into-tuesday">JPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into Tuesday</a></li>
</ul>
Photo via Shutterstock

Earnings

Markets

Alcoa Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

LQR House shares are trading lower after the company announced a $46 million offering.

Piper Sandler analyst Nathan Race assumes West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTBA#NASDAQ">WTBA</a>) with a Neutral rating and announces Price Target of $21.5.

Initiation

WTBA

Piper Sandler Assumes West Bancorp at Neutral, Announces Price Target of $21.5

UBS analyst Douglas Harter maintains PennyMac Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) with a Neutral and raises the price target from $110 to $115.

PFSI

UBS Maintains Neutral on PennyMac Financial Servs, Raises Price Target to $115

Financial and Strategic Considerations
Carbon-offset-enabled trades may command price premiums over traditional contracts. Based on initial modeling and comparable market data, Davis Commodities anticipates potential incremental high-margin revenue of $10–$15 million by the end of 2026, subject to execution timelines, client uptake, and market conditions.
This initiative complements Davis Commodities' broader commitment to sustainable trade infrastructure and builds on recent developments in blockchain traceability, tokenized trade models, and the company's exploration of a Solana-based digital reserve strategy.

DTCK

Davis Commodities Anticipates Potential Incremental High-Margin Revenue Of $10M - $15M By The End Of 2026

General

IXHL

CORRECTION: Incannex Healthcare Appointed Douglas Kirsch To Its Advisory Board On June 24

UBS analyst Douglas Harter maintains Finance of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOA#NYSE">FOA</a>) with a Neutral and raises the price target from $22.5 to $25.

Comments

KKR Real Est Finance Tr

Actualités

Dernières nouvelles pour KKR Real Est Finance Tr (NYSE:KREF) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL